Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter O'Kane

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 15, 2026
Optical coherence tomography versus angiographic guidance in true unprotected left main bifurcation disease: an OCTOBER substudyEmil N Holck, Lene D Andreasen, Omeed Neghabat, et al.
Journal of the American College of Cardiology|May 17, 2024
Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic CardiomyopathySaad M Ezad, Margaret McEntegart, Matthew Dodd, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 14, 2022
Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trialRobert-Jan van Geuns, Chang Chun-Chin, Margaret B McEntegart, et al.
Journal of Cardiovascular Computed Tomography|October 10, 2022
Randomized comparison of chest pain evaluation with FFR<sub>CT</sub> or standard care: Factors determining US costsMark A Hlatky, Sam Wilding, Beth Stuart, et al.
Heart (British Cardiac Society)|December 16, 2023
Very early invasive strategy in higher risk non-ST-elevation acute coronary syndrome: the RAPID NSTEMI trialThomas A Kite, Andrew Ladwiniec, John P Greenwood, et al.
Journal of the American Heart Association|January 26, 2021
Achieving Optimal Medical Therapy: Insights From the ORBITA TrialMichael Foley, Christopher A Rajkumar, Matthew Shun-Shin, et al.
Journal of the American College of Cardiology|November 13, 2013
A prospective randomized trial of everolimus-eluting stents versus bare-metal stents in octogenarians: the XIMA Trial (Xience or Vision Stents for the Management of Angina in the Elderly)Adam de Belder, Jose M de la Torre Hernandez, Ramon Lopez-Palop, et al.
Journal of the American College of Cardiology|April 18, 2026
Randomized, Placebo-Controlled Trial of Chronic Total Occlusion Percutaneous Coronary Intervention in Stable Angina: The ORBITA-CTO TrialSarosh Khan, Uzma Sajjad, Samer Fawaz, et al.
Interventional Cardiology (London, England)|March 14, 2025
Percutaneous Coronary Intervention in the UK: Recommendations of the British Cardiovascular Intervention SocietyNick Curzen, Helen Routledge, Samuel McGrath, et al.
European Heart Journal|July 16, 2021
Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trialNick Curzen, Zoe Nicholas, Beth Stuart, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 15, 2026
Optical coherence tomography versus angiographic guidance in true unprotected left main bifurcation disease: an OCTOBER substudyEmil N Holck, Lene D Andreasen, Omeed Neghabat, et al.
Journal of the American College of Cardiology|May 17, 2024
Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic CardiomyopathySaad M Ezad, Margaret McEntegart, Matthew Dodd, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 14, 2022
Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trialRobert-Jan van Geuns, Chang Chun-Chin, Margaret B McEntegart, et al.
Journal of Cardiovascular Computed Tomography|October 10, 2022
Randomized comparison of chest pain evaluation with FFR<sub>CT</sub> or standard care: Factors determining US costsMark A Hlatky, Sam Wilding, Beth Stuart, et al.
Heart (British Cardiac Society)|December 16, 2023
Very early invasive strategy in higher risk non-ST-elevation acute coronary syndrome: the RAPID NSTEMI trialThomas A Kite, Andrew Ladwiniec, John P Greenwood, et al.
Journal of the American Heart Association|January 26, 2021
Achieving Optimal Medical Therapy: Insights From the ORBITA TrialMichael Foley, Christopher A Rajkumar, Matthew Shun-Shin, et al.
Journal of the American College of Cardiology|November 13, 2013
A prospective randomized trial of everolimus-eluting stents versus bare-metal stents in octogenarians: the XIMA Trial (Xience or Vision Stents for the Management of Angina in the Elderly)Adam de Belder, Jose M de la Torre Hernandez, Ramon Lopez-Palop, et al.
Journal of the American College of Cardiology|April 18, 2026
Randomized, Placebo-Controlled Trial of Chronic Total Occlusion Percutaneous Coronary Intervention in Stable Angina: The ORBITA-CTO TrialSarosh Khan, Uzma Sajjad, Samer Fawaz, et al.
Interventional Cardiology (London, England)|March 14, 2025
Percutaneous Coronary Intervention in the UK: Recommendations of the British Cardiovascular Intervention SocietyNick Curzen, Helen Routledge, Samuel McGrath, et al.
European Heart Journal|July 16, 2021
Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trialNick Curzen, Zoe Nicholas, Beth Stuart, et al.
Pageof 7